|
Symbol
|
RMA93V | RMBA5V | CBRBKB | RMBAQV | RMAPBV | RMALEV | OVHRCH | RMBNOV | KZBIDU | ABWMSQ | CIEBKB | RMA54V | RMBRQV | PEZRCH | ABKBTQ | Z0AASZ | RMA6EV | RMAWAV | PJPRCH | RMADDV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible |
|
Sous-jacent
|
Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Sandoz Group AG / Straumann Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Sandoz Group AG / Straumann Hldg. AG | Alcon / Novartis AG / Sandoz | Lonza Group N / Sandoz Group AG / Siegfried Hldg. AG / Straumann Hldg. AG | Clariant AG / Sandoz Group AG / Tecan Group AG | Bachem Hldg. AG / Novartis AG / Roche PS / Sandoz Group AG | Sandoz Group AG / Sika AG / Stadler Rail AG | Clariant AG / Lonza Group N / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Straumann Hldg. AG | Alcon / Nestlé S.A. / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Givaudan / Lonza Group N / Sandoz Group AG | Alcon / Galderma Group AG / Novartis AG / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Straumann Hldg. AG | Alcon / Sandoz Group AG / Straumann Hldg. AG | Aryzta AG / Compagnie Financière Richemont SA / Sandoz Group AG | Alcon / Sandoz Group AG / Sonova Hldg. AG / VAT Group | Galderma Group AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
12.01.2027 | 05.01.2027 | 02.11.2026 | 09.02.2027 | 07.09.2026 | 15.03.2027 | 16.09.2026 | 26.10.2026 | 30.10.2026 | 30.10.2026 | 18.11.2026 | 02.11.2026 | 22.11.2027 | 18.11.2026 | 12.11.2026 | 11.11.2026 | 07.12.2026 | 21.12.2026 | 23.12.2026 | 05.01.2027 |
| Demande | 100,40 | 100,60 | 99,30 | 99,20 | - | 68,20 | 71,97 | 101,00 | 77,00 | 87,61 | 99,70 | 99,30 | 92,30 | 97,20 | 99,85 | - | 97,20 | 72,20 | 98,92 | 100,80 |
| Offre | 101,40 | 101,60 | - | 100,20 | - | - | - | 102,20 | 78,00 | - | 100,50 | 100,30 | 93,30 | - | 100,65 | - | 98,20 | - | - | 101,80 |